Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

SACOMM Conference at UFS
2007-09-14

The Department of Communication and Information Studies at the University of the Free State (UFS) is hosting the annual conference of the South African Communications Association (SACOMM). The theme of the conference is "The African Landscape"

Date: 19-21 September 2007
Venue: CR Swart Auditorium, UFS Main Campus
Time: Please refer to the attached programme

The keynote address, entitled "The concept of an African University", will be delivered by Prof. Achille Mbembe from the University of the Witwatersrand (WITS) on 19 September 2007 at 14:00.

Enquiries can be directed to Ms Mercia Coetzee at 051 401 2872 or 082 257 4566.

Download Conference programme (Pdf format)

Department receives sponsorship from ABSA Bank

The University of the Free State’s (UFS) Department of Communication and Information Studies received a sponsor of R20 000 from ABSA Bank. The department is hosting the annual national conference of the South African Communication Association (SACOMM) from 19-21 September 2007 on the Main Campus in Bloemfontein and the money will be used for the conference. During the hand-over of the sponsorship were, from the left are: Ms Mercia Coetzee (Lecturer at the department and organiser of the conference) and Ms Eloïse Calitz (ABSA Bank).
Photo: Supplied
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept